UB-312 in Patients With Synucleinopathies

NCT05634876 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Multiple System Atrophy
Parkinson Disease

Interventions

BIOLOGICAL: UB-312 Injection
BIOLOGICAL: Placebo Injection

Sponsor

NYU Langone Health